Randomized phase III trial comparing cisplatin–etoposide to carboplatin–paclitaxel in advanced or metastatic non-small cell lung cancer von Belani, C. P., Lee, J. S., Socinski, M. A., Robert, F., Waterhouse, D., Rowland, K., Ansari, R., Lilenbaum, R., Natale, R. B.

Volltext

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer von Bonomi, P.D., Gandara, D., Hirsch, F.R., Kerr, K.M., Obasaju, C., Paz-Ares, L., Bellomo, C., Bradley, J.D., Bunn Jr, P.A., Culligan, M., Jett, J.R., Kim, E.S., Langer, C.J., Natale, R.B., Novello, S., Pérol, M., Ramalingam, S.S., Reck, M., Reynolds, C.H., Smit, E.F., Socinski, M.A., Spigel, D.R., Vansteenkiste, J.F., Wakelee, H., Thatcher, N.

Volltext

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas von ANTMAN, K, CROWLEY, J, DOROSHOW, J. H, AISNER, J, PUGH, R. P, WEISS, R. B, COOPER, B. A, CLAMOND, G. H, BAKER, L. H, BALCERZAK, S. P, RIVKIN, S. E, WEISS, G. R, ELIAS, A, NATALE, R. B, COOPER, R. M, BARLOGIE, B, TRUMP, D. L

Volltext

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study von TAYLOR, C. W, GREEN, S, BEARDEN, J. D, MAILLIARD, J. A, OSBORNE, C. K, DALTON, W. S, MARTINO, S, RECTOR, D, INGLE, J. N, ROBERT, N. J, BUDD, G. T, PARADELO, J. C, NATALE, R. B

Volltext

Suramin Therapy for Patients With Symptomatic Hormone-Refractory Prostate Cancer: Results of a Randomized Phase III Trial Comparing Suramin Plus Hydrocortisone to Placebo Plus Hydr... von SMALL, E. J, MEYER, M, MARSHALL, M. E, REYNO, L. M, MEYERS, F. J, NATALE, R. B, LENEHAN, P. F, LIANG CHEN, SLICHENMYER, W. J, EISENBERGER, M

Volltext

Experience With New Chemotherapeutic Agents in Non-small Cell Lung Cancer von Natale, Ronald B.

Volltext

A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A southwest oncology group study von Balcerzak, Stanley P., Benedetti, Jacqueline, Weiss, Geoffrey R., Natale, Ronald B.

Volltext

Phase I Trial of the Combination of Irinotecan, Paclitaxel, and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer von SOCINSKI, Mark A, SANDLER, Alan B, MILLER, Langdon L, LOCKER, Paula K, HANOVER, Cristy K, ELFRING, Gary L, ISRAEL, Valerie K, PIROTTA, Nicoletta, NATALE, Ronald B

Volltext

The Emerging Role of Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors von Langer, Corey J., Natale, Ronald B.

Volltext

A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study von J K Weick, J Crowley, R B Natale, B L Hom, S Rivkin, C A Coltman, Jr, S A Taylor, R B Livingston

Volltext

470PA phase I study of tinostamustine in patients (pts) with advanced solid tumours von Mita, A, Loeffler, M, Bui, N, Remmy, D, Mehrling, T, Mita, M, Rimel, B J, Natale, R B, Kummar, S

Volltext

A Multicenter Phase II Trial of Losoxantrone (DuP-941) in Hormone-refractory Metastatic Prostate Cancer von HUAN, S. D, NATALE, R. B, STEWART, D. J, SARTIANO, G. P, STELLA, P. J, ROBERTS, J. D, SYMES, A. L, FINIZIO, M

Volltext

Intestinal differentiation and p53 gene alterations in barrett's esophagus and esophageal adenocarcinoma von Moore, Jason H., Lesser, Eric J., Erdody, David H., Natale, Ronald B., Orringer, Mark B., Beer, David G.

Volltext

Concurrent chemotherapy immediately following erlotinib (E) or gefitinib (G) induced apoptosis in previously untreated patients with advanced or metastatic non-small cell lung canc... von Natale, R. B.

Volltext

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2 von HERBST, Roy S, GIACCONE, Giuseppe, WOLF, Michael K, KREBS, Annetta D, AVERBUCH, Steven D, OCHS, Judith S, GROUS, John, FANDI, Abderrahim, JOHNSON, David H, SCHILLER, Joan H, NATALE, Ronald B, MILLER, Vincent, MANEGOLD, Christian, SCAGLIOTTI, Giorgio, ROSELL, Rafael, OLIFF, Ira, REEVES, James A

Volltext

Surgical Factors Influence Bladder Cancer Outcomes: A Cooperative Group Report von HERR, Harry W, FAULKNER, James R, GROSSMAN, H. Barton, NOTATE, Ronald B, WHITE, Ralph Devere, SAROSDY, Michael F, CRAWFORD, E. David

Volltext

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer von RINEHART, John, ADJEI, Alex A, GULYAS, Stephen, MITCHELL, David Y, HERRERA, Roman, SEBOLT-LEOPOLD, Judith S, MEYER, Mark B, LORUSSO, Patricia M, WATERHOUSE, David, HECHT, J. Randolph, NATALE, Ronald B, HAMID, Oday, VARTERASIAN, Mary, ASBURY, Peggy, KALDJIAN, Eric P

Volltext

Phase II study of 5‐fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A southwest oncology group study von Berenberg, Jeffrey L., Tangen, Catherine, Macdonald, John S., Hutchins, Laura F., Natale, Ronald B., Oishi, Noboru, Guy, Jerry T., Fleming, Thomas R.

Volltext

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer: A Randomized Trial von Kris, Mark G, Natale, Ronald B, Herbst, Roy S, Lynch, Jr, Thomas J, Prager, Diane, Belani, Chandra P, Schiller, Joan H, Kelly, Karen, Spiridonidis, Harris, Sandler, Alan, Albain, Kathy S, Cella, David, Wolf, Michael K, Averbuch, Steven D, Ochs, Judith J, Kay, Andrea C

Volltext

Phase I Clinical Study of Pertuzumab, a Novel HER Dimerization Inhibitor, in Patients With Advanced Cancer von AGUS, David B, GORDON, Michael S, KELSEY, Stephen M, FYFE, Gwen, TAYLOR, Charles, NATALE, Ronald B, KARLAN, Beth, MENDELSON, David S, PRESS, Michael F, ALLISON, David E, SLIWKOWSKI, Mark X, LIEBERMAN, Gracie

Volltext